I think I mentioned this probability once in passing a few months before February (just can't find it in all the clutter, here), but we certainly discussed it, as did Peter Loftus, back in February 2010.
Today's announcement, after market close, that Kenneth Frazier has been named the overall President of New Merck (not just the global Human Health Care businesses president) is the clearest handwriting on the wall, yet -- that he will be tapped to take Dick Clark's place, when Clark reaches mandatory retirement age, mid 2011. From the presser:
. . . .As company president, Mr. Frazier will lead Merck's three largest worldwide divisions responsible for pharmaceutical and vaccine sales and marketing, research and development, and manufacturing and supply. He will ensure the effective collaboration among these global and interdependent divisions, which is critical to the success of the November 2009 merger of Merck and Schering-Plough and the company's long-term performance. . . .
I think Frazier will make a fine Chairman and CEO.
No comments:
Post a Comment